Astrocyte Pharmaceuticals Inc, a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, is pleased to announce the initiation...
House Rx and Marin Cancer Care announced a partnership to bring House Rx's point-of-care specialty medicine dispensing into Marin Cancer Care's care delivery model. Called 'medically integrated dispensing,'...
With the accelerated approval on January 6, 2023 for early Alzheimer's disease, Eisai/Biogen's Leqembi became only the second approved disease-modifying therapy (DMT) for early Alzheimer's...
Nordic Consulting, a global health and technology consulting company, announced the expansion of its offerings to include a full suite of managed services. The...
